H. Uderman

发表

Clinical studies with synthetic ovine corticotropin-releasing factor.

J. Rivier, W. Nicholson, D. Orth, 1985, Federation proceedings.

Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in man.

W. Vale, J. Rivier, W. Nicholson, 1983, The Journal of clinical endocrinology and metabolism.

Pharmacokinetics of Fosinopril and Hydrochlorothiazide in Healthy Elderly and Young Men

B. Stouffer, B. Ameer, J. Brennan, 1999 .

Effect of tyramine on myocardial catecholamine release in coronary heart disease.

M. Forman, M. Goldberg, D. Robertson, 1984, The American journal of cardiology.

Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man.

M. Vance, L. Frohman, W. Vale, 1984, The Journal of clinical investigation.

Omapatrilat: Neurohormonal and Pharmacodynamic Profile When Administered with Furosemide

J. Manning, W. Liao, C. Delaney, 2001, Journal of clinical pharmacology.

Interaction of nefazodone (N) and fluoxetine (F)

M. Marino, H. Uderman, K. Langenbacher, 1996 .

Effects of indomethacin on systemic and coronary hemodynamics in patients with coronary artery disease.

M. Forman, D. Robertson, E. Jackson, 1985, American heart journal.

Effect of Nifedipine on the Steady-State Pharmacokinetics and Pharmacodynamics of Irbesartan in Healthy Subjects

N. Ford, M. Marino, H. Uderman, 1998, Journal of cardiovascular pharmacology and therapeutics.

A Dose‐Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Gatifloxacin in Healthy Adult Men

F. LaCreta, D. Gajjar, G. Kollia, 2000, Pharmacotherapy.

Pharmacokinetics and Pharmacodynamics of Irbesartan in Healthy Subjects

N. Ford, M. Marino, H. Uderman, 1998, Journal of clinical pharmacology.

Attenuation of noradrenergic neurotransmission by the thromboxane synthetase inhibitor, UK 38,485.

R. Branch, W. Herzer, E. Jackson, 1984, Life sciences.

Attenuation of the development of hypertension in spontaneously hypertensive rats by the thromboxane synthetase inhibitor, 4'-(imidazol-1-yl) acetophenone.

E. Jackson, R. Workman, H. Uderman, 1982, Prostaglandins.

Fosinopril and Hydrochlorothiazide Combination versus Individual Components: Lack of a Pharmacokinetic Interaction

J. Brennan, W. Liao, Shu-Ying Chang, 1999, The Annals of pharmacotherapy.

Pharmacokinetic and Pharmacodynamic Evaluation During Coadministration of Nefazodone and Propranolol in Healthy Men

P. Marathe, D. Salazar, R. Raymond, 1995, Journal of clinical pharmacology.

Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.

A. N. Alexander, R. Evans, D. Rabin, 1984, The Journal of clinical endocrinology and metabolism.

Effects of Food on the Pharmacokinetics of Irbesartan/Hydrochlorothiazide Combination Tablet

W. Shyu, D. Greene, N. Vachharajani, 1998 .

Effects of Standard and Supratherapeutic Doses of Nelfinavir on Cardiac Repolarization: A Thorough QT Study

Kaori Ito, P. Glue, P. Clax, 2009, Journal of clinical pharmacology.

Prostaglandin biosynthesis does not participate in hypercapnia-induced cerebral vasodilatation in the dog.

R. Branch, J. Zimmerman, J. Oates, 1983, The Journal of pharmacology and experimental therapeutics.

The effect of nefazodone on the single-dose pharmacokinetics of phenytoin in healthy male subjects.

M. Marino, H. Uderman, K. Langenbacher, 1997, Journal of clinical psychopharmacology.

A059: Omapatrilat is not a diuretic: single- and multiple-dose analysis of the urinary excretion of sodium

W. Liao, C. Delaney, A. Meier, 2000 .

Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjects.

M. Jemal, N. Ford, B. Swanson, 2003, British journal of clinical pharmacology.

Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite.

Pinaki Biswas, P. Biswas, P. Glue, 2009, British journal of clinical pharmacology.

Pharmacokinetic and Pharmacodynamic Evaluation of Warfarin and Nefazodone Coadministration in Healthy Subjects

P. Chaikin, R. Dockens, D. Salazar, 1995, Journal of clinical pharmacology.

Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in the adult spontaneously hypertensive rat.

E. Jackson, D. Puett, R. Workman, 1984, Journal of cardiovascular pharmacology.

Effects of thromboxane synthase inhibitors on renal function

R. Branch, G. FitzGerald, W. Herzer, 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

Open‐Label, Nonrandomized Study of the Effects of Gatifloxacin on the Pharmacokinetics of Midazolam in Healthy Male Volunteers

F. LaCreta, G. Kollia, D. Grasela, 2000, Pharmacotherapy.